(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SPECIALTY THERAPY ACCESS RESOURCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SPECIALTY THERAPY ACCESS RESOURCES

ST13

US500000088869571

Class

35, 36

Filing

88869571

Registration

6450652

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

08/10/2026

Trademark type

Word

Nice classes

35, 36

Filing date

04/13/2020

Registration date

08/10/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/10/2021

Last transaction

08/10/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

04/01/2019

First use in commerce

04/01/2019

Drawing code

4

Owner type

03

Owner location

EAST WINDSOR, NJ, US

Examiner

NOBLE, ANNIE MELISSA

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ACROTECH BIOPHARMA INC.
Acrotech Biopharma, LLC
Acrotech Biopharma, LLC

Representatives

Lynn E. Rzonca Ballard Spahr LLP

Technical classification

Nice Classes

Class 35Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Consultation in the field of the purchase of pharmaceuticalspharmaceutical cost management services; consultation in the field of the purchase of pharmaceuticalsbusiness administration of patient reimbursement programs

Class 36

Consultation in the field of the purchase of pharmaceuticalsfinancial administration of patient reimbursement programs; consultation in the field of the purchase of pharmaceuticalsfinancial administration of patient reimbursement programs

Publications

History of USPTO decisions and trademark events.

30 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/10/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/05/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/05/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/05/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/05/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/14/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/29/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/29/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/29/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/29/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/29/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

08/10/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/06/2021

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

06/29/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/27/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/27/2021

ALIE

ASSIGNED TO LIE

05/25/2021

NREV

NOTICE OF REVIVAL - E-MAILED

02/23/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/22/2021

PETG

PETITION TO REVIVE-GRANTED

02/22/2021

PROA

TEAS PETITION TO REVIVE RECEIVED

02/22/2021

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

02/01/2021

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

02/01/2021

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

07/15/2020

GPRA

PRIORITY ACTION E-MAILED

07/15/2020

CPRA

PRIORITY ACTION WRITTEN

07/15/2020

DOCK

ASSIGNED TO EXAMINER

06/30/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/21/2020

NWAP

NEW APPLICATION ENTERED

04/16/2020

Continuous trademark protection

Get notified about every new filing that threatens SPECIALTY THERAPY ACCESS RESOURCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.